All patients | Elective patients | Urgent patients | p | |
---|---|---|---|---|
Age (years) | 80 [76–84] | 80 [76–84]/79.7 ± 6.2 | 79 [73–85] | 0.233 |
Male gender | 47.7% (301/631) | 46.9% (271/578) | 56.6% (30/53) | 0.197 |
BMI | 26.5 [24.1–29.5] | 26.7 [24.1–29.8] | 25.6 [23.3–27.9] | 0.027 |
DM | 27.3% (172/631) | 27% (155/578) | 32% (17/53) | 0.411 |
Prior stroke | 9.4% (59/631) | 9.2% (53/578) | 11.3% | 0.607 |
COPD | 14.1% (89/631) | 13.8% | 17% | 0.53 |
Prior Cardiac surgery | 22.8% (144/631) | 21.8% | 34% | 0.043 |
Valve surgery | 7.8% (49/631) | 7.3% | 13.2% | 0.122 |
LVEF < 30% | 6.0% (38/631) | 3.8% | 30.2% | 0.001 |
GFR < = 30 ml/min/1,73 m2 | 26.8% (169/631) | 26.5% | 30.2% | 0.559 |
Creatinine (umol/l) | 96 [79–119] | 94.5 [78–116] | 115.5 [88–147] | 0.001 |
Logistic Euroscore | 11.3 [7.8–18.3] | 11.9 [7.7–18.1] | 17.0 [10.1–25.6] | 0.001 |
Euroscore II | 3.0 [1.8–4.9] | 2.9 [1.7–4.5] | 5.3 [3.4 -10.9] | < 0.001 |
Apical access | 24.6% (155/631) | 23.8% | 32.1% | 0.184 |
Complications stroke | 2.1% (13/631) | 2.1% | 1.9% | 0.926 |
Renal failure | 0.6% (4/631) | 0.5% | 1.9% | 0.230 |
PM within 30 days | 9.7% (61/598) | 9.5% | 11.3% | 0.308 |
Pre-TAVI hospitalisation (days) | 1 [1–1] | 1 [1–1] | 18 [10–28] | < 0.001 |
Post-TAVI hospitalisation (days) | 4 [3–6] | 4 [3–6] | 6 [4–9] | < 0.001 |
In-hospital mortality | 3.8% (24/631) | 3.1% | 11.3% | 0.003 |
1-year mortality | 10.1% (64/631) | 8.5% | 28.3% | 0.001 |